Skip to main content
SpringerLink
Log in

Fertility preservation in women with endometrial cancer

  • review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

Fertility preservation should only be offered to patients with endometrial cancer stage Ia grade 1 (G1), who present without myometrial invasion or where the cancer has invaded less than 50% of the myometrium, with no evidence of pathological lymph nodes or no evidence of synchronous or metachronous ovarian tumor. It is estimated that about 22% will achieve successful pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Cancer Society. Detailed guide: endometrial cancer: what are the risk factors for endometrial cancer? American Cancer Society, Atlanta, GA. 2005. http://www.cancer.org/cancer/endometrialcancer/detailedguide/endometrial-uterine-cancerrisk-factors. Accessed 14.04.2020

  2. https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Gebaermutterkoerperkrebs/gebaermutterkoerperkrebs.html. Accessed 14.09.2020

  3. American Cancer Society. Cancer facts and figures 2014. American Cancer Society, Atlanta. 2014. http://www.cancer.org/acs/groups/content/research/documents/webcontent/acspc-042151.pdf. Accessed 14.09.2020

  4. Guillon S, Popescu N, Phelippeau J, Koskas M. A systematic review and meta-analysis, of prognostic factors for remission in fertility sparingmanagement of endometrialatypical hyperplasia and adenocarcinoma. Int J Gynecol Obstet. 2019; https://doi.org/10.1002/ijgo.12882.

    Article  Google Scholar 

  5. Wang Y, et al. Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia. Int J Gynecol Cancer. 2019;29:699–704. https://doi.org/10.1136/ijgc-2018-000081.

    Article  PubMed  Google Scholar 

  6. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol. 1984;64:417–20.

    CAS  PubMed  Google Scholar 

  7. Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575–80.

    Article  Google Scholar 

  8. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod. 2012;27:1327–31.

    Article  Google Scholar 

  9. Tran BN, Connell PP, Waggoner S, et al. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol. 2000;23:476–80.

    Article  CAS  Google Scholar 

  10. Montz FJ, Bristow RE, Bovicelli A, et al. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol. 2002;186:651–7.

    Article  CAS  Google Scholar 

  11. Duska LR, Garrett A, Rueda BR. Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001;83:388–93.

    Article  CAS  Google Scholar 

  12. Huang SY, Jung SM, Ng KK, et al. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment. Gynecol Oncol. 2005;97:652–5.

    Article  CAS  Google Scholar 

  13. National Institute for Health and Clinical Excellence CG44. Heavy menstrual bleeding. 2007.

    Google Scholar 

  14. American College of Obstetricians and Gynecologists. Practice bulletin. Diagnosis of abnormal uterine bleeding in reproductive aged women. Obstet Gynecol. 2012;128:1–11.

    Google Scholar 

  15. Pennant ME, Mehta R, Moody P, Hackett G, Prentice A, Sharp SJ, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124:404–11.

    Article  CAS  Google Scholar 

  16. Obermair A, Baxter E, Brennan DJ, et al. Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstet Gynecol Sci. 2020;63(4):417–31. https://doi.org/10.5468/ogs.19169.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Walsh C, Holschneider C, Hoang Y. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693–9.

    Article  Google Scholar 

  18. Morice P, Fourchotte V, Sideris L. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol. 2005;96:245–8.

    Article  Google Scholar 

  19. Zarbo G, Caruso G, Caruso S, Mangano U, Zarbo R. Endometrial cancer: preoperative evaluation of myometrial infiltration magnetic resonance imaging versus transvaginal ultrasonography. Eur J Gynaecol Oncol. 2000;21(1):95–7. PMID: 10726632.

    CAS  PubMed  Google Scholar 

  20. Nouri K, Reinthaller A. Fertilitätserhalt bei prämenopausalen Frauen mit # Endometriumkarzinom im frühen, niedriggradigen Stadium. Speculum. 2015;33(1):12–6.

    Google Scholar 

  21. Cosgrove CM, Cohn DE, Hampel H, et al. Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. Gynecol Oncol. 2017;146:588–95.

    Article  CAS  Google Scholar 

  22. Cohn DE, Frankel WL, Resnick KE, et al. Improved survival with an intact DNA mismatch repair system in endometrial cancer. Obstet Gynecol. 2006;108:1208–15.

    Article  CAS  Google Scholar 

  23. Wei J, Zhang W, Feng L, Gao W. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: a meta-analysis and systematic review. Medicine (Baltimore). 2017;96:e8034.

    Article  Google Scholar 

  24. Son J, Carr C, Yao M, et al. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years. Int J Gynecol Cancer. 2020;30:631–9.

    Article  Google Scholar 

  25. Harrison RF, He W, Fu S, et al. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer oratypical hyperplasia. Am J Obstet Gynecol. 2019;221:474.e1–11.

    Google Scholar 

  26. Mazzon I, Corrado G, Masciullo V, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010;93:1286–9.

    Article  Google Scholar 

  27. Ichinose M, Fujimoto A, Osuga Y, et al. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia. Int J Gynecol Cancer. 2013;23(2):288–93. https://doi.org/10.1097/IGC.0b013e31827c18a1.

    Article  PubMed  Google Scholar 

  28. Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012;207:266.e1–266.e12.

    Article  Google Scholar 

  29. Fan Z, Li H, Hu R, Liu Y, Liu X, Gu L. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis. Int J Gynecol Cancer. 2018;28(2):385–393. https://doi.org/10.1097/IGC.0000000000001164. PMID: 29266019.

    Article  PubMed  Google Scholar 

  30. Shih KK, Garg K, Levine DA, et al. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40 years of age and younger. Gynecol Oncol. 2011;123:88–94.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VivaNeo Austria, Klagenfurt, Austria

    Helena Bralo MD

  2. Wunschkind Clinic Dr. Brunbauer, Vienna, Austria

    Maria Roethlisberger MD

  3. VivaNeo Austria, Hadikgasse 82, 1140, Vienna, Austria

    Kazem Nouri MD

Authors
  1. Helena Bralo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Roethlisberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazem Nouri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazem Nouri MD.

Ethics declarations

Conflict of interest

H. Bralo, M. Roethlisberger and K. Nouri declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bralo, H., Roethlisberger, M. & Nouri, K. Fertility preservation in women with endometrial cancer. memo 13, 421–425 (2020). https://doi.org/10.1007/s12254-020-00661-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-020-00661-6

Keywords

Search

Navigation